Minerva Neurosciences' IPO

Minerva Neurosciences raised a round of funding on July 01, 2014. Investors include Public.

Minerva Neurosciences is a clinical-stage biopharmaceutical company focused on the development and commercialization of a portfolio of product candidates to treat central nervous system (CNS) diseases…

Articles about Minerva Neurosciences' IPO: